Protection of enkephalins from enzymatic degradation utilizing selective metal-chelating inhibitors
- 1 August 1983
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 91 (4), 353-361
- https://doi.org/10.1016/0014-2999(83)90158-9
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Kidney neutral endopeptidase and the hydrolysis of enkephalin by synaptic membranes show similar sensitivity to inhibitorsBiochemical Journal, 1982
- Phosphoryl-Leu-Phe: A potent inhibitor of the degradation of enkephalin by enkephalinaseEuropean Journal of Pharmacology, 1981
- In vivo potentiation of [D-ALA2]met-enkephalin amide central effects after administration of an enkephalinase inhibitorEuropean Journal of Pharmacology, 1981
- The effect of barbiturates on the degradation of enkephalin by brain enzymesLife Sciences, 1981
- Inhibition of enkephalin-degrading enzymes from rat brain and of thermolysin by amino acid hydroxamatesLife Sciences, 1980
- Two distinct enkephalinases: Solubilization, partial purification and separation from angiotensin converting enzymeLife Sciences, 1979
- Inhibitory potency of various peptides on enkephalinase activity from mouse striatumBiochemical and Biophysical Research Communications, 1979
- Hydrolysis of enkephalin by cultured human endothelial cells and by purified peptidyl dipeptidaseBiochemical Pharmacology, 1978
- Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acidsBiochemistry, 1977
- The Use of Esters of N-Hydroxysuccinimide in Peptide SynthesisJournal of the American Chemical Society, 1964